Concepedia

Sven J. Henninger

SJ

Statistics

Publications

3

Citations

63

H-Index

3

Active since

2020

Affiliations

University Medical Center of the Johannes Gutenberg University Mainz(Current)

Johannes Gutenberg University Mainz

Jena University Hospital

University of Regensburg

Sven J. Henninger is an author at University Medical Center of the Johannes Gutenberg University Mainz specializing in drug discovery, radiation oncology, and medicine.

Top concepts

Publications per year

2020–2021

3

Publications

3

Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3

Vanessa Wachholz, Al‐Hassan M. Mustafa, Yanira Zeyn et al. · Archives of Toxicology · 2021 · 26 citations · Full text

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells

Mandy Beyer, Sven J. Henninger, Patricia S. Haehnel et al. · Cell chemical biology · 2021 · 23 citations

, , +9

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia

Andreas Sellmer, Bernadette Pilsl, Mandy Beyer et al. · European Journal of Medicinal Chemistry · 2020 · 14 citations · Full text

, , +9

1–3 of 3